Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bioblast Pharma Ltd (NASDAQ:ORPN)

0.9801
Delayed Data
As of Dec 09
 -0.2399 / -19.66%
Today’s Change
0.92
Today|||52-Week Range
7.95
-74.67%
Year-to-Date
No recent news for Bioblast Pharma Ltd.

Today’s Trading

Previous close1.22
Today’s open1.27
Day’s range0.92 - 1.28
Volume524,105
Average volume (3 months)63,174
Market cap$20.0M
Dividend yield--
Data as of 3:59pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-89.47%
Earnings growth (this year)+6.48%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
DRIODarioHealth Corp-0.05-1.44%
PZRXPhaseRx Inc-0.03-1.84%
WGBSWaferGen Bio-systems...+0.04+0.83%
CLSNCelsion Corp+0.03+4.46%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$15.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Fredric D. Price
Chief Medical Officer &
VP-Research
Warren W. Wasiewski
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs